Karvy CMD Parthasarathy resigns as Independent Director of Granules India Board
C Parthasarathy, Chairman and Managing Director of the Hyderabad-based Karvy Group, has resigned as an Independent Director on Board of pharmaceutical27-12-2019
27-12-2019
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Resignation of Director
Intimation under Regulation 30 of the Regulation - Resignation of Mr. C. Parthasarathy as an Independent Director.26-12-2019
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Resignation of Director
Intimation under Regulation 30 of the Regulation - Resignation of Mr. C. Parthasarathy as an Independent Director.26-12-2019
Granules India gets USFDA nod for allergy treatment drug
Granules India on Tuesday said the US health regulator had given its approval to the abbreviated new drug application filed by the drug firm for Lora24-12-2019
Granules India Ltd - 532482 - Received Approval For ANDA Filed By Granules India Limited
Received approval for ANDA filed by Granules India Limited24-12-2019
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Investor Meeting20-12-2019
Granules India Ltd - 532482 - Update On NDMA In Metformin Manufactured By Granules India Limited
Update on NDMA in Metformin manufactured by Granules India Limited19-12-2019
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Investor Meeting16-12-2019
Granules India share price rises 1% on stake sale in Chinese JV
The conclusion of the transaction is subject to the fulfillment of certain closing conditions and regulatory approvals.16-12-2019
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Updates on Joint Venture
Company has entered into an agreement with Hubei Biocause Heilen Pharmaceutical CO., Limited., Joint Venture Partner13-12-2019